三级片无码高清免费国产,中文字幕一区二区三区乱,国内精品久久久久久99蜜桃,亚洲一区电影网站在线观看

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

特级做a爰片久久毛片a片喷水| 成人网站在线观看| 亚洲白嫩小受男同gv在线观看| 成人性爱视频在线观看| 国产精品麻豆强奸小视频| 天使萌大战黑人在线播放| 日韩伦理一区二区三区电影| 亚洲日本一区二区三区不卡| 日韩欧国产美一区二区在线| 男人的天堂好色在线观看| 无码色偷偷亚洲国内自拍| 精品国产乱药久久久久久| 2021AV亚洲天堂网| 无码的3d里番| 久久精品这里热有精品6| 亚洲另类春色偷拍在线观看| 超碰大香蕉免费在线观看 | 国产精品按摩师| 欧美久久国产精品让激情| 久久久久亚洲av无码专区首| 91精品视频在线观看不卡| 一级片一区二区中文字幕| 欧美久久久久久又粗又大| 成人片夜AV片在线播放| 青青草无码精品伊人久久| 黄色av网站大全在线观看| 久久人妻av一区二区三区| 日本一在线中文字幕dvd| 国产综合精品99久久久久| 亚洲人成网站观看在线播放| 久久中文字幕一区二区不卡| 国产精品亚洲av一区二区| 国产区二区三区免费精品| 国产精品三级在线免费观看| 人妻精品久久久久中文字幕69| 性色做爰片在线观看ww| 欧美日韩精品高清一区二区| 精品成人一区二区三区四区| 无码乱码av天堂一区二区| 久久精品国产精品国产精品污| 久久久久久这里只有精品|